Bristol-Myers Squibb Co (NYSE:BMY)

47.79
Delayed Data
As of 4:00pm ET
 -0.42 / -0.87%
Today’s Change
44.30
Today|||52-Week Range
63.69
-8.06%
Year-to-Date
Bristol-Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
6:26pm / Zacks.comZAK - Paid Partner Content
Roche Reports Positive Data on Rituxan for Pemphigus Vulgaris
Jun 13 / Zacks.comZAK - Paid Partner Content
Top Analyst Reports for Broadcom, Amgen & NVIDIA
1:01pm / Zacks.comZAK - Paid Partner Content
Roche's Rituxan Gets Priority Review for Blood Disorder
Jun 12 / Zacks.comZAK - Paid Partner Content
Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio
10:36am / Zacks.comZAK - Paid Partner Content
Bristol-Myers Squibb (BMY) Gains As Market Dips: What You Should Know
Jun 12 / Zacks.comZAK - Paid Partner Content
Is It Too Late to Buy Celgene Stock?
Jun 16 / MotleyFool.comFOO - Paid Partner Content
Zacks.com featured highlights include: CDW, Bristol-Myers, Celgene, PepsiCo and North...
Jun 12 / Zacks.comZAK - Paid Partner Content
Mallinckrodt Presents Encouraging Data on Acthar Gel for RA
Jun 14 / Zacks.comZAK - Paid Partner Content
Bristol-Myers Squibb (BMY) is a Top Dividend Stock Right Now: Should You Buy?
Jun 12 / Zacks.comZAK - Paid Partner Content

Today’s Trading

Previous close48.21
Today’s open48.28
Day’s range47.71 - 48.68
Volume11,523,657
Average volume (3 months)16,524,106
Market cap--
Data as of 4:00pm ET, 06/18/2019

Growth & Valuation

Earnings growth (last year)+393.92%
Earnings growth (this year)+5.27%
Earnings growth (next 5 years)+5.50%
Revenue growth (last year)+8.59%
P/E ratio15.2
Price/Sales3.77
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-0.15-0.15%
NVONovo Nordisk+1.18+2.31%
GSKGlaxoSmithKline+0.29+0.73%
TAKTakeda Pharmaceutica...+0.15+0.88%
Data as of 4:02pm ET, 06/18/2019

Financials

Next reporting dateJuly 25, 2019
EPS forecast (this quarter)$1.05
Annual revenue (last year)$22.6B
Annual profit (last year)$4.9B
Net profit margin21.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Giovanni Caforio
CFO, EVP &
Head-Global Business Operations
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts